Certified by Founder Lodge
Gimv
Belgium - Antwerp
INVESTOR
1 Disclosed Funding Rounds $105,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Guiding companies - Benefitting society
Gimv is a European investment company with more than 40 years' experience in private equity. Listed on Euronext Brussels, we have 2 billion EUR AUM
| Company | Date | Round | Raised |
|---|---|---|---|
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Complement Therapeutics |
April, 18 ,2023 | Series A | $78,929,000 |
 Kinaset Therapeutics |
January, 13 ,2026 | Series B | $103,000,000 |
 EXCIVA GmbH |
January, 20 ,2026 | Series B | $59,817,135 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
